Ontology highlight
ABSTRACT:
SUBMITTER: Cazzola M
PROVIDER: S-EPMC3085864 | biostudies-other | 2011 May
REPOSITORIES: biostudies-other
British journal of pharmacology 20110501 1
Despite the passionate debate over the use of β(2) -adrenoceptor agonists in the treatment of airway disorders, these agents are still central in the symptomatic management of asthma and COPD. A variety of β(2) -adrenoceptor agonists with long half-lives, also called ultra long-acting β(2) -adrenoceptor agonists (ultra-LABAs; indacaterol, olodaterol, vilanterol, carmoterol, LAS100977 and PF-610355) are currently under development with the hopes of achieving once-daily dosing. It is likely that t ...[more]